Stephen T. Worland, EVP, Pharmaceuticals at ANADYS PHARMACEUTICALS INC (ANDS), sold 4,000 shares at $16.00 ($64K) on 2006-03-16, disclosed to the SEC on 2006-03-17.
Scheduled sale ($64k) by EVP, Pharmaceuticals under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ANDS | SELL | 2006-03-17 | $42K | — | Filing → |